Phamaceutical Compostions for Preventing and Treating Vascular Endothelial Cell Dyfunction Comprising Nafamostat Mesilate

摘要

The present invention relates to a pharmaceutical composition for preventing and treating vascular endothelial cell disease comprising nafamostat mesilate as an active ingredient. The pharmaceutical composition according to the present invention has an anti-inflammatory effect of vascular endothelial cells by blocking the inflammatory reaction mechanism by TNF-a of vascular endothelial cells and exhibits vasorelaxant effect. Thus, the pharmaceutical composition for vascular inflammation diseases and vasoconstriction Can be used as the composition.